País: Regne Unit
Idioma: anglès
Font: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ascorbic acid
Zanza Specials International Ltd
A11GA01
Ascorbic acid
50mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09060301; GTIN: 5060033710692 5060033710609
Patient Information Lea f l e t A S C O R B I C A C I D 50 M G T AB L E T S This medicine will be called Ascorbic Acid T a b l e t s in this l ea f l e t . READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • This medicine is only for you. Do not give it to anyone else to take. It may harm them, even if their symptoms are the same as yours. • If you have any further questions, please ask your doctor or pharmacist. • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. IN THIS L E A FL E T : 1. What Ascorbic Acid Tablets are and what they a r e used f o r 2. Before you take Ascorbic Acid T a b l e t s 3. How to take Ascorbic Acid T a b l e t s 4. Possible side e ff e c t s 5. How to store Ascorbic Acid T a b l e t s 6. Further i n f o rm a t io n 1. WHAT ASCORBIC ACID TABLETS ARE A ND WHAT THEY ARE USED F O R These tablets contain the active ingredient, a s c o r b i c acid. Ascorbic acid is the chemical name for V i t a m i n C. The tablets can be used to increase the amount o f Vitamin C in the d i e t . Vitamin C Tablets are used to treat patients wi t h scurvy or they can be used by people who are at r i s k of Vitamin C d e f i c i e n c y . 2. BEFORE YOU TAKE ASCORBIC ACID TA B LE T S SOME PEOPLE MUST NOT TAKE THESE T A B L E T S. DO NOT TAKE THESE TABLETS IF : • You know you are allergic to ascorbic acid or to any of the other ingredients ( t h e s e are listed in Section 6 ) • You suffer from hyperoxaluria ( e x c e ss oxalic acid i n the ur i n e ) . YOU MUST BE ESPECIALLY CAREFUL IF : • You are pregnant or b r ea s t f ee d i n g . • You have an intolerance to some sugars. T h e s e tablets contain lactose and su c r o s e. If any of the conditions above apply to you, p l ea s e discuss your treatment with your doctor before t a ki n g this m e d i c i n e. TAKING OTHER M E DICINES Ascorbic Acid Tablets can affect some o t Llegiu el document complet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ascorbic Acid 50mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 50mg of ascorbic acid. Excipient(s) with known effect Lactose monohydrate For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. White to off-white convex tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prevention and treatment of scurvy. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults and children over 6 years: _ Prophylactic: 25 – 75 mg daily. Therapeutic: Not less than 250mg daily in divided doses. Maximum of 1000mg daily. _Children under 6 years: _ This unit dosage form is unsuitable for children under 6 years. _Elderly: _As for other adults. As the dietary intake of vitamin C may be less in the elderly, they have greater risk of presenting with vitamin C deficiency. Method of administration For oral administration. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Ascorbic acid should not be given to patients with hyperoxaluria. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Increased intake of ascorbic acid over a prolonged period may result in an increased renal clearance of ascorbic acid, and deficiency may result if the intake is reduced or withdrawn rapidly (see section 4.8). Interference with serological testing Ascorbic acid may interfere with tests and assays for urinary glucose, giving false-negative results with methods utilising glucose oxidase with indicator (e.g. Labstix, Tes-Tape) and false-positive results with neocuproine methods. Estimation of uric acid by phosphotungstate or uricase with copper reduction and measurement of creatinine in non-deproteinised serum may also be affected. High doses of ascorbic acid may give false-negative readings in faecal occult blood tests. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine. 4 Llegiu el document complet